BPCA
VRTX icon

Bank Pictet & Cie (Asia)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank Pictet & Cie (Asia)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,388
Closed -$481K – 97
2021
Q2 		$481K Buy
2,388
+120
+5% +$25.1K 0.13% 80
2021
Q1 		$487K Buy
2,268
+268
+13% +$58.9K 0.15% 76
2020
Q4 		$473K Buy
+2,000
New +$459K 0.15% 79

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank Pictet & Cie (Asia)'s VRTX Position: Q3 2021 in Review

Bank Pictet & Cie (Asia) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 2,388 shares — an estimated $481K sold.

Bank Pictet & Cie (Asia) first reported a position in VRTX in Q4 2020 and held it in 3 quarters. The position peaked at $487K in Q1 2021. 934 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

  • Bank Pictet & Cie (Asia) reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Bank Pictet & Cie (Asia) sold 2,388 Vertex Pharmaceuticals shares in Q3 2021, an estimated $481K.
  • Bank Pictet & Cie (Asia) first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Bank Pictet & Cie (Asia)'s Vertex Pharmaceuticals position peaked at $487K in Q1 2021.
  • 934 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q3 2021, filed 10 Nov 2021.